Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press37010.17650/1994-4098-2008-0-3-75-80GYNECOLOGY. TREATMENTГИНЕКОЛОГИЯ. ЛЕЧЕНИЕ5-YEAR SURVIVAL OF PATIENTS WITH STAGE II UTERINE CANCER DEPENDING ON MORPHOLOGIC FEATURES OF TUMORПЯТИЛЕТНЯЯ ВЫЖИВАЕМОСТЬ БОЛЬНЫХ РАКОМ ТЕЛА МАТКИ II СТАДИИ В ЗАВИСИМОСТИ ОТ МОРФОЛОГИЧЕСКИХ ПРИЗНАКОВ ОПУХОЛИMustafinaYe. A.МустафинаЕ. А.
Russian Federation
BarinovV. V.БариновВ. В.
Russian Federation
ShabanovM. A.ШабановМ. А.
Russian Federation
BokinaL. I.БокинаЛ. И.
Russian Federation
KozachenkoV. P.КозаченкоВ. П.
Russian Federation
PeskovaV. I.ПесковаВ. И.
Russian Federation
State Institution N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences, MoscowГУ РОНЦ им. Н.Н. Блохина РАМН, Москва160820083758017092014170920142008https://ojrs.abvpress.ru/ojrs/article/view/370

Retrospective data of treatment results of 109 patients with rarely observed stage II uterine cancer, admitted to N.N. Blokhin Russian Cancer Research Center from 1980 to 2000 is analyzed. Correlation of overall 5-year survival rates of stage IIA and IIB uterine can- cer patients with a number of tumor morphologic features is studied. The influence of some non-elucidated morphologic features of stage IIA and IIB uterine cancer such as the degree of cellular anaplasia, the depth of tumor invasion into the uterine neck, lymho- vascular invasion into the myometrium and uterine neck, microscopic vessels density in the area of the most extensive invasion, the presence of necrotic areas in the tumor tissue on long-term treatment results are analyzed.

ПЯТИЛЕТНЯЯ ВЫЖИВАЕМОСТЬ БОЛЬНЫХ РАКОМ ТЕЛА МАТКИ II СТАДИИ В ЗАВИСИМОСТИ ОТ МОРФОЛОГИЧЕСКИХ ПРИЗНАКОВ ОПУХОЛИ

1. Announcements: FIGO stages 1988 revision. Gynecol Oncol 1989;35:125—6.Announcements: FIGO stages 1988 revision. Gynecol Oncol 1989;35:125—6.2. Бохман Я.В., Бонтэ Я., Вишневский А.С. и др. Гормонотерапия рака эндометрия. СПб., Гиппократ; 1993.Бохман Я.В., Бонтэ Я., Вишневский А.С. и др. Гормонотерапия рака эндометрия. СПб., Гиппократ; 1993.3. Максимов С.Я. Минимальный рак эндометрия. СПб., Гиппократ; 1992.Максимов С.Я. Минимальный рак эндометрия. СПб., Гиппократ; 1992.4. Ahmad K., Kin Y.V., Deppe G. et al. Radiation therapy in stage II carcinoma of endometrium. Cancer 1989;63:854—8.Ahmad K., Kin Y.V., Deppe G. et al. Radiation therapy in stage II carcinoma of endometrium. Cancer 1989;63:854—8.5. Berman M.L., Muhammed A.A., Kanbor A. et al. Risk factors and progno- sis in stage II endometrial cancer. Gynecol Oncol 1982;14:49—61.Berman M.L., Muhammed A.A., Kanbor A. et al. Risk factors and progno- sis in stage II endometrial cancer. Gynecol Oncol 1982;14:49—61.6. Blake P., Lodge N., A'Hern R. An audit of outcome of adjuvant post-opera- tive radiotherapy for 52 women with stage II carcinoma of endometrium. Br J Radiol 2000;73:987—93.Blake P., Lodge N., A'Hern R. An audit of outcome of adjuvant post-opera- tive radiotherapy for 52 women with stage II carcinoma of endometrium. Br J Radiol 2000;73:987—93.7. Novak's Gynecology. J.S. Berek, E.Y. Adashi, P.A. Hillard. Eds. Philadelphia, Williams and Wilkins; 2002.Novak's Gynecology. J.S. Berek, E.Y. Adashi, P.A. Hillard. Eds. Philadelphia, Williams and Wilkins; 2002.8. Wolfson A.H., Sightler S.E., Markoe A.M. et al. The prognostic sig- nificance of surgical staging for carcino- ma of the endometrium. Gynecol Oncol 1992;45:142—6.Wolfson A.H., Sightler S.E., Markoe A.M. et al. The prognostic sig- nificance of surgical staging for carcino- ma of the endometrium. Gynecol Oncol 1992;45:142—6.9. Абрамова Т.А. Лабораторный скрининг опухолевых заболеваний. Авто- реф. дис. ... канд. биол. наук. Томск; 1997.Абрамова Т.А. Лабораторный скрининг опухолевых заболеваний. Авто- реф. дис. ... канд. биол. наук. Томск; 1997.10. Баринов В.В. Рак тела матки (диагностика, лечение, факторы прогно- за). Дис. ... докт. мед. наук. М.; 1999.Баринов В.В. Рак тела матки (диагностика, лечение, факторы прогно- за). Дис. ... докт. мед. наук. М.; 1999.11. Бохман Я.В. Руководство по онкогинекологии. Л., Медицина; 1989.Бохман Я.В. Руководство по онкогинекологии. Л., Медицина; 1989.12. Олейник В.В. Актуальные вопросы онкологии. В сб.: Материалы международного симпозиума. Санкт-Петербург, 14—17 мая 1996 г. СПб.; 1996. с. 216—7.Олейник В.В. Актуальные вопросы онкологии. В сб.: Материалы международного симпозиума. Санкт-Петербург, 14—17 мая 1996 г. СПб.; 1996. с. 216—7.13. Cornelison T.L., Trimble E.L., Kosary C.L. SEER Data, Corpus Uteri Cancer: Treatment trends versus survival for FIGO stage II, 1988—1994. Gynecol Oncol 1999;74:350—5.Cornelison T.L., Trimble E.L., Kosary C.L. SEER Data, Corpus Uteri Cancer: Treatment trends versus survival for FIGO stage II, 1988—1994. Gynecol Oncol 1999;74:350—5.14. Creasman W.T., Weed J.C. Carcinoma of endometrium (FIGO stages I and II): clinical features and manage- ment. In: Gynecologic Oncology, ed. 2. London, Churchill Livingstone; 1992.Creasman W.T., Weed J.C. Carcinoma of endometrium (FIGO stages I and II): clinical features and manage- ment. In: Gynecologic Oncology, ed. 2. London, Churchill Livingstone; 1992.15. Eltabbakh G.H., Alison D., et al. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 1999;74:80—5.Eltabbakh G.H., Alison D., et al. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 1999;74:80—5.16. Feltmate C.M., Duska L.R., Chiao Y. et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol 1999;73:407—11.Feltmate C.M., Duska L.R., Chiao Y. et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol 1999;73:407—11.17. Ng T.Y., Nicklin J.L., Perrin L.C. et al. Postoperative vaginal vault brachy thera- py for node0negative stage II (occult) endometrial carcinoma. Gynecol Oncol 2001;81:193—5.Ng T.Y., Nicklin J.L., Perrin L.C. et al. Postoperative vaginal vault brachy thera- py for node0negative stage II (occult) endometrial carcinoma. Gynecol Oncol 2001;81:193—5.18. Pettersson F. Annual report on the results of treatment in gynecologic can- cer. Stockholm, Sweden: Radiumhemmet. FIGO;1995. p. 65—82.Pettersson F. Annual report on the results of treatment in gynecologic can- cer. Stockholm, Sweden: Radiumhemmet. FIGO;1995. p. 65—82.19. Sartori E., Gadducci A., Landoni F. et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adju- vant radiation therapy. Int J Gynecol Cancer 2001;11:430—7.Sartori E., Gadducci A., Landoni F. et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adju- vant radiation therapy. Int J Gynecol Cancer 2001;11:430—7.20. Irvin W.P., Rice L.W. Benefit in treatment of endometrial carcinoma. J Reprod Med 2002;47(3):173—89.Irvin W.P., Rice L.W. Benefit in treatment of endometrial carcinoma. J Reprod Med 2002;47(3):173—89.21. Jobsen J.J., Schutter E.M., Meerwaldt J.H. Treatment results in women with clinical stage I and patho- logic stage II endometrial carcinoma. Int Gynecol Cancer 2001;11(1):49—53.Jobsen J.J., Schutter E.M., Meerwaldt J.H. Treatment results in women with clinical stage I and patho- logic stage II endometrial carcinoma. Int Gynecol Cancer 2001;11(1):49—53.22. Sevin B.U., Knapstein P.G., Kochli O.R. Multymodality therapy in gynecologic oncology. Stuttgart, N Y, Thieme; 1996. p. 31—53.Sevin B.U., Knapstein P.G., Kochli O.R. Multymodality therapy in gynecologic oncology. Stuttgart, N Y, Thieme; 1996. p. 31—53.23. COZA-NZ-UK Endometrial cancer study group. Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 1996;6:102—7.COZA-NZ-UK Endometrial cancer study group. Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 1996;6:102—7.24. Kadar N., Malfetano J.H., Homesley H.D. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet Gynecol 1992;80:655—9.Kadar N., Malfetano J.H., Homesley H.D. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet Gynecol 1992;80:655—9.25. Morrow C.P., Brain N.B., Roberts J. et al. Relationship between surgical- pathyological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 1991;40: 55—65.Morrow C.P., Brain N.B., Roberts J. et al. Relationship between surgical- pathyological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 1991;40: 55—65.